Antibody cocktail against SARS-CoV-2 spike protein Grant US-11834493-B2 United States of America 05 Dec 2023
Compositions and methods for treating a COVID-19 infection Grant US-11746144-B2 United States of America 05 Sep 2023
ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Application EP-4209507-A1 European Patent Office 12 Jul 2023
METHODS FOR TREATING OR PREVENTING SARS-COV-2 INFECTIONS AND COVID-19 WITH ANTI-SARS-COV-2… Application WO-2023081434-A3 World Intellectual Property Organisation (WIPO) 15 Jun 2023
NEUTRALIZING ANTI-SARS-COV-2 HUMAN ANTIBODIES Application EP-4177266-A1 European Patent Office 10 May 2023
Binding agent with enhanced affinity for the prevention and treatment of sarbecovirus-relat… Application FR-3128713-A1 France 05 May 2023
NEUTRALISING POLYPEPTIDES AND APPLICATIONS THEREOF Application WO-2023057448-A1 World Intellectual Property Organisation (WIPO) 13 Apr 2023
Anti-spike glycoprotein antibodies and the therapeutic use thereof Grant US-11623949-B2 United States of America 11 Apr 2023
BROADLY NEUTRALIZING ANTIBODY COMBINATION THERAPIES FOR SARS-COV-2 INFECTION Application WO-2023039442-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2023
ANTI-SARS2-S ANTIBODIES Application WO-2023036982-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2023
POTENTLY NEUTRALIZING NOVEL HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 (COVID-19) Application WO-2023026207-A1 World Intellectual Property Organisation (WIPO) 02 Mar 2023
A SURROGATE CELL-BASED CORONA VIRUS SPIKE PROTEIN BLOCKING ASSAY Application WO-2023006267-A1 World Intellectual Property Organisation (WIPO) 02 Feb 2023
A SURROGATE CELL-BASED CORONA VIRUS SPIKE PROTEIN BLOCKING ASSAY Application EP-4124865-A1 European Patent Office 01 Feb 2023
NEUTRALIZING ANTI-SARS- COV-2 ANTIBODIES AND METHODS OF USE THEREOF Application WO-2022235867-A3 World Intellectual Property Organisation (WIPO) 19 Jan 2023
ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Application WO-2023287875-A1 World Intellectual Property Organisation (WIPO) 19 Jan 2023
ANTI-SARS-COV-2 ANTIBODIES AND USE THEREOF IN THE TREATMENT OF SARS-COV-2 INFECTION Application WO-2022263638-A1 World Intellectual Property Organisation (WIPO) 22 Dec 2022
ANTIBODY BINDING TO RBD OF THE SPIKE PROTEIN OF SARS-COV-2 AND A METHOD FOR QUANTIFYING… Application WO-2022237924-A1 World Intellectual Property Organisation (WIPO) 17 Nov 2022
ANTIBODY BINDING TO RBD OF SPIKE PROTEIN OF SARS-COV-2 AND A METHOD FOR QUANTIFYING… Application EP-4089112-A1 European Patent Office 16 Nov 2022
HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF Application WO-2022228827-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2022
POLYCLONAL ANTIBODIES AGAINST SARS-COV-2 AND IMPLEMENTATIONS THEREOF Application WO-2022224271-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022
ANTIBODIES THAT BIND TO MULTIPLE SARBECOVIRUSES Application WO-2022204202-A1 World Intellectual Property Organisation (WIPO) 29 Sep 2022
ANTI-SARS-COV-2 ANTIBODIES AND USE THEREOF IN THE TREATMENT OF SARS-COV-2 INFECTION Application WO-2022162587-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2022
ANTI-SARS-COV-2 SPIKE GLYCOPROTEIN ANTIBODIES AND THE THERAPEUTIC USE THEREOF Application WO-2022165039-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2022
ANTIBODIES NEUTRALIZING SARS-COV-2 Application WO-2022153212-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
USE OF VACCINE COMPOSITIONS BASED ON SARS-COV-2 RECEPTOR BINDING DOMAIN IN DELIVERING… Application WO-2022127946-A1 World Intellectual Property Organisation (WIPO) 23 Jun 2022
Anti-SARS-COV-2 antibodies and uses thereof Grant US-11365239-B2 United States of America 21 Jun 2022
ANTI-SARS-COV-2 ANTIBODY MOLECULES Application WO-2022112392-A1 World Intellectual Property Organisation (WIPO) 02 Jun 2022
ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES Application WO-2022115538-A1 World Intellectual Property Organisation (WIPO) 02 Jun 2022
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2… Grant US-11345741-B2 United States of America 31 May 2022
ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES AND COCKTAIL THEREOF Application WO-2022101839-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES Application WO-2022098870-A1 World Intellectual Property Organisation (WIPO) 12 May 2022
ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF Application WO-2022090353-A1 World Intellectual Property Organisation (WIPO) 05 May 2022
ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS Application WO-2022081436-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
SARS-COV-2 CORONAVIRUS-NEUTRALIZING ANTIBODY Application WO-2022079359-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
ANTIBODY AGAINST CORONAVIRUS Application WO-2022059801-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022
ANTIBODY MOLECULES TO CORONAVIRUS AND USES THEREOF Application WO-2022026592-A3 World Intellectual Property Organisation (WIPO) 24 Mar 2022
CORONA VIRUS SPIKE PROTEIN-TARGETING ANTIBODIES AND USE THEREOF Application WO-2022023292-A3 World Intellectual Property Organisation (WIPO) 10 Mar 2022
SARS-COV-2 ANTIBODIES FOR TREATMENT AND PREVENTION OF COVID-19 Application WO-2022034044-A1 World Intellectual Property Organisation (WIPO) 17 Feb 2022
ANTI-SARS-COV-2 ANTIBODIES Application WO-2022035918-A1 World Intellectual Property Organisation (WIPO) 17 Feb 2022
SEROLOGICAL ANTIBODY-BASED DIAGNOSTICS OF SARS-COV-2 INFECTION Application WO-2022022927-A1 World Intellectual Property Organisation (WIPO) 03 Feb 2022
ANTI-SARS CORONA VIRUS-2 SPIKE PROTEIN ANTIBODIES Application WO-2022027037-A1 World Intellectual Property Organisation (WIPO) 03 Feb 2022
NEUTRALIZING ANTIBODIES TO SARS CORONAVIRUS-2 Application WO-2022003530-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
MULTISPECIFIC CORONAVIRUS ANTIBODIES Application WO-2022006562-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
METHODS FOR TREATING OR PREVENTING SARS-CoV-2 INFECTIONS AND COVID-19 WITH ANTI-SARS-CoV-2… Application WO-2021247779-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST SARS-COV-2 GLYCOPROTEIN S Application WO-2021244852-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST SARS-COV-2 GLYCOPROTEIN S Application EP-3919126-A1 European Patent Office 08 Dec 2021
ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Application WO-2021242815-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
ANTIBODIES AGAINST SARS-COV-2 Application WO-2021226560-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Application EP-3889177-A1 European Patent Office 06 Oct 2021
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2… Application WO-2021195418-A1 World Intellectual Property Organisation (WIPO) 30 Sep 2021
ANTI-CORONAVIRUS ANTIBODIES AND METHODS OF USE Application WO-2021183359-A1 World Intellectual Property Organisation (WIPO) 16 Sep 2021